Investors love a good story, and Ingersoll Rand (IR)
is certainly obliging them, as this company checks almost all of the
Street's preferred thematic boxes right now. Ingersoll Rand is strongly
leveraged to the short-cycle industrial recovery, passed through the
downturn with excellent decremental margins, offers outsized synergy
opportunities, has M&A optionality, and offers a market share
growth/leverage story, as pre-break up Ingersoll Rand didn't invest as
much into its industrial businesses. Frankly, all that the story lacks
is leverage to industrial software, HVAC/green retrofit, or life
sciences/bioproduction, and even on the latter point, there is leverage
to medical/scientific fluidics.
I thought Ingersoll Rand already
had a pretty healthy valuation in August, but I grossly underestimated
how much more the Street would pay for the company's leverage to the
post-pandemic recovery and that thematic excellence. With that, the
shares are up about 40% since my last article, roughly doubling the return of the larger industrial group and handily outperforming Atlas Copco (OTCPK:ATLKY) as well.
I
still have issues with valuation, as mid-to-high single-digit revenue
and FCF growth and over two points of operating margin improvement from
2021 to 2023 can't really get me to a good place on valuation. I don't
discount the upside potential from more M&A moves, nor the
opportunities to gain share or the value of a good story, but the
drivers for further outperformance seem more limited to me.
Read the full article here:
Ingersoll Rand Checking All Of The Street's Preferred Thematic Boxes